Jim Welle

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: United States

Consulting Services

Admin and Customer Support Biostatistics Scientific Writing Pharma-CRO-Device

Areas Of Interest

Adipose Tissue, Subcutaneous Acute Necrotizing Encephalitis, Herpetic Hydrochloride, Nebivolol Iceland Cutdown, Venous Cell, Lymphatic Endothelial Centers for Disease Control and Prevention (U.S.) Pseudointestinal Obstruction Syndrome Minocycline Menstrual Cycle, Luteal Phase Congenital Hyperinsulinisms Imiquimod Biogonadil Air Ambulance Genes, Pleiotropic Cornaceae Cytotoxic T Lymphocyte Antigen 4 Health Psychologies Dehydrogenase Deficiency, Dihydropyrimidine Passive Dependent Personality Kroener Fimbriectomy Healths, Environmental Baroreceptors Baseline Survey Stanolone Receptors Evolution, Chemical Tegmentum Pontis

Professional Narrative

Dr. Jim Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 2000
Medical Writer, Harvard Med 2005

Education

Master of Science in physician assistant, Harvard Medical School 1991
Master of Science in physician assistant, Yale School of Medicine 1994

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :